Cover Image

Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

Saved in:
Bibliographic Details
Main Authors: Lorenzen, Sylvie (Author) , Haag, Georg Martin (Author) , Eisenmenger, Andreas (Author) , Karapanagiotou-Schenkel, Irini (Author) , Lordick, Florian (Author)
Format: Article (Journal)
Language:English
Published: 16 February 2015
In: European journal of cancer
Year: 2015, Volume: 51, Issue: 5, Pages: 569-576
ISSN:1879-0852
DOI:10.1016/j.ejca.2015.01.059
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.ejca.2015.01.059
Get full text
Author Notes:Sylvie Lorenzen, Jorge Riera Knorrenschild, Georg-Martin Haag, Michael Pohl, Peter Thuss-Patience, Florian Bassermann, Ulrike Helbig, Florian Weißinger, Elisabeth Schnoy, Klaus Becker, Gertraud Stocker, Josef Rüschoff, Andreas Eisenmenger, Irini Karapanagiotou-Schenkel, Florian Lordick
Description
Item Description:Gesehen am 27.09.2016
Physical Description:Online Resource
ISSN:1879-0852
DOI:10.1016/j.ejca.2015.01.059

Similar Items